Astria Therapeutics, Inc.·4

Nov 23, 4:12 PM ET

Komjathy Andrew 4

4 · Astria Therapeutics, Inc. · Filed Nov 23, 2021

Insider Transaction Report

Form 4
Period: 2021-11-19
Komjathy Andrew
Chief Commercial Officer
Transactions
  • Purchase

    Common Stock

    2021-11-19$6.70/sh+100$670100 total

Documents

1 file
  • 4
    tm2133657-1_4seq1.xmlPrimary

    OWNERSHIP DOCUMENT